PANQOLI (quality of life instrument)
OtherA quality of life instrument, the PANQOLI, will be administered prior to endoscopic intervention, and at 1,3, 6 and 12 months post-intervention.
Other names: Visual Analog Scale for pain
NCT Number: NCT03632616
This study seeks to evaluate the effect of endoscopic interventions on quality of life in patients with chronic pancreatitis. Quality of life will be evaluated using the PANQOLI, a validated quality of life instrument specific to chronic pancreatitis. Endoscopic interventions will include pancreatic duct dilation and stenting, celiac plexus block, lithotripsy and removal of pancreatic duct stones, and pseudocyst drainage.
Interested in participating?
Request Info18 year and older
All sexes
Observational
University of Colorado Anschutz Medical Center, Aurora, Colorado, United States
This is a multicenter prospective cohort study assessing the impact of endoscopic interventions on patients with chronic pancreatitis. Patients with chronic pancreatitis referred for endoscopic treatment, including pancreatic duct dilation and stenting, pseudocyst drainage, celiac plexus blocks, and pseudocyst drainage/necrosectomy will be enrolled in this study. They will receive a baseline evaluation using the PANQOLI, a chronic pancreatitis-specific quality of life instrument, in addition to a visual analog scale to measure their pain. Demographic and endoscopic features will be collected in addition to pain medication use. Patients will receive follow-up at 1, 3, and 6 months post-intervention consisting of the PANQOLI, visual analog scale for pain, and pain medication use.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A quality of life instrument, the PANQOLI, will be administered prior to endoscopic intervention, and at 1,3, 6 and 12 months post-intervention.
Other names: Visual Analog Scale for pain
Time frame: The outcome will be measured at 1, 3, and 6 months post-intervention.
The primary outcome will be the change in quality of life using the PANQOLI (PANcreatitis Quality of Life Instrument) after endoscopic intervention.
Time frame: The outcome will be measured at 1, 3, and 6 months post-intervention.
The secondary outcome will include the change in pain using the Visual Analog Scale (VAS) for pain after endoscopic intervention
Time frame: The outcome will be measured at 1, 3, and 6 months post-intervention.
The secondary outcome will include the change in pain medication use after endoscopic intervention.
University of Colorado, Denver
Other
Quality of Life Evaluation of Endoscopic Interventions in Chronic Pancreatitis
Acronym: QOLAPI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06936800
Chronic Disease, Chronic Pancreatitis
Jinan, Wenhuaxi Road, China
View Trial DetailsNCT06283576
Behavior, Chronic Disease
Stockholm, Sweden
View Trial DetailsNCT03324698
Chronic Disease, Chronic Pancreatitis
Shanghai, China
View Trial DetailsNCT06386224
Acute Recurrent Pancreatitis, Chronic Disease
Seattle, Washington, United States
View Trial Details